Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

ALEXANDER CONSTANTIN GELOU

Allopathic & Osteopathic Physicians Family Medicine

NPI
1316200603
CMS profile
798522
Location
BELLINGHAM, WA

General Payments · PY2018–2024

$1,225.39

  • Reported across 35 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$308.13

14 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $308.13 14

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Lilly USA, LLC $65.37 3
Novo Nordisk AS $62.08 3
SANOFI-AVENTIS U.S. LLC $46.65 2
Alexion Pharmaceuticals, Inc. $45.28 2
Insulet Corporation $31.94 1
Abbott Laboratories $24.04 1
Medtronic, Inc. $19.51 1
Xeris Pharmaceuticals, Inc. $13.26 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $410.08 4
PY2019 $100.04 1
PY2022 $120.19 6
PY2023 $286.95 10
PY2024 $308.13 14

Payment records · PY2024 (14)

Sorted by paying entity, then date · as published by CMS

Program year 2024 2018201920222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Abbott Laboratories $24.04 03/07/2024 Food and Beverage Undisputed 01/23/2026 1124983148 CMS
Alexion Pharmaceuticals, Inc. $28.71 08/19/2024 Food and Beverage Undisputed 01/23/2026 1093945709 CMS
Alexion Pharmaceuticals, Inc. $16.57 09/11/2024 Food and Beverage Undisputed 01/23/2026 1094019398 CMS
Insulet Corporation $31.94 11/20/2024 Food and Beverage Undisputed 01/23/2026 1116821894 CMS
Lilly USA, LLC $17.58 02/29/2024 Food and Beverage Undisputed 01/23/2026 1136019722 CMS
Lilly USA, LLC $22.41 05/03/2024 Food and Beverage Undisputed 01/23/2026 1136022564 CMS
Lilly USA, LLC $25.38 06/12/2024 Food and Beverage Undisputed 01/23/2026 1136019956 CMS
Medtronic, Inc. $19.51 07/01/2024 Food and Beverage Undisputed 01/23/2026 1117156142 CMS
Novo Nordisk Inc $14.03 04/12/2024 Food and Beverage Undisputed 01/23/2026 1097329481 CMS
Novo Nordisk Inc $24.83 09/11/2024 Food and Beverage Undisputed 01/23/2026 1097046895 CMS
Novo Nordisk Inc $23.22 11/20/2024 Food and Beverage Undisputed 01/23/2026 1097092549 CMS
SANOFI-AVENTIS U.S. LLC $25.22 01/26/2024 Food and Beverage Undisputed 01/23/2026 1139857490 CMS
SANOFI-AVENTIS U.S. LLC $21.43 03/20/2024 Food and Beverage Undisputed 01/23/2026 1139857504 CMS
Xeris Pharmaceuticals, Inc. $13.26 08/05/2024 Food and Beverage Undisputed 01/23/2026 1144585528 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.